An Overview of Cardiac Management in Neuromuscular Disease
Renee M. Hickey, John D. Cullen, George M. Sachs*
Identifiers and Pagination:Year: 2016
Issue: Suppl-1, M2
First Page: 82
Last Page: 88
Publisher Id: TOCMJ-10-82
Article History:Received Date: 29/9/2015
Revision Received Date: 08/10/2015
Acceptance Date: 25/11/2015
Electronic publication date: 27/05/2016
Collection year: 2016
open-access license: This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) (https://creativecommons.org/licenses/by-nc/4.0/legalcode), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
Muscular dystrophy and myasthenia gravis are two neuromuscular disorders that can involve significant cardiovascular complications. The frequency and severity of cardiac pathology varies widely among the muscular dystrophies. In some, it is nearly inevitable and requires regular evaluation. In others, assessment of cardiac function can be more symptom-driven. On-ly a minority of myasthenic patients manifest disease-related cardiovascular complications; however, their presentation can be rapidly progressive and life-threatening..